<DOC>
	<DOCNO>NCT00436475</DOCNO>
	<brief_summary>The purpose randomize trial quantify effect vitamin D calcium supplementation beta-cell function , insulin sensitivity , glucose tolerance systemic inflammation cardiometabolic outcomes ambulatory adult high risk type 2 diabetes .</brief_summary>
	<brief_title>Vitamin D Calcium Homeostasis Prevention Type 2 Diabetes</brief_title>
	<detailed_description>There animal human observational evidence suggest vitamin D calcium important modifying t2DM risk critical gap knowledge clinical magnitude association t2DM potential mechanism human . We conduct randomize trial quantify effect vitamin D calcium supplementation beta-cell function , insulin sensitivity , glucose tolerance systemic inflammation cardiometabolic outcomes ambulatory adult high risk t2DM . We anticipate research propose application significant provide basis define feasible nutritional intervention promote prevention t2DM . Based result propose study future work area , vitamin D calcium supplementation assume important role treatment t2DM prevention disease 41 million Americans risk develop t2DM .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metabolic Syndrome X</mesh_term>
	<mesh_term>Glucose Intolerance</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<mesh_term>Calcium , Dietary</mesh_term>
	<mesh_term>Calcium Carbonate</mesh_term>
	<criteria>Ethnicity : ethnic group Gender : men woman Age 1 . Lower age limit : 40 year inclusive 2 . Upper age limit : NONE BMI 1 . Lower BMI limit : 25 inclusive 2 . Upper BMI limit : 40 inclusive Glucose Intolerance / Mild Diabetes define 1 . Fasting glucose ≥100 mg/dl OR 2 . 2hr glucose OGTT ≥140 mg/dl OR 3 . 5.8 ≤ Hemoglobin A1c ≤ 7 Major Diabetes require pharmacotherapy Smoking Hyperparathyroidism Hypercalcemia ( Calcium &gt; 10.5 mg/dl ) Kidney stone Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Glucose intolerance</keyword>
	<keyword>Type 2 diabetes mellitus</keyword>
	<keyword>Metabolic syndrome</keyword>
</DOC>